You have 9 free searches left this month | for more free features.

ziltivekimab

Showing 1 - 5 of 5

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Trial in India (Ziltivekimab, Placebo)

Not yet recruiting
  • Cardiovascular Risk
  • Acute Myocardial Infarction (AMI)
  • Ziltivekimab
  • Placebo
  • New Delhi, Delhi, India
  • +12 more
Nov 8, 2023

Chronic Kidney Disease and Systemic Inflammation Trial in Beijing (Ziltivekimab, Placebo)

Active, not recruiting
  • Chronic Kidney Disease and Systemic Inflammation
  • Ziltivekimab
  • Placebo
  • Beijing, Beijing, China
  • +3 more
Nov 10, 2022

Chronic Kidney Disease, Inflammation, Cardiovascular Risk Trial in Ehime (Ziltivekimab, Placebo (ziltivekimab))

Completed
  • Chronic Kidney Disease
  • +2 more
  • Ziltivekimab
  • Placebo (ziltivekimab)
  • Ehime, Japan
    Novo Nordisk Investigational Site
Oct 26, 2021

Heart Failure Trial in Worldwide (Ziltivekimab, Placebo)

Not yet recruiting
  • Heart Failure
  • Ziltivekimab
  • Placebo
  • Alexander City, Alabama
  • +420 more
Dec 23, 2022

Cardiovascular Risk, Chronic Kidney Disease, Inflammation Trial in Worldwide (Ziltivekimab, Placebo (ziltivekimab))

Recruiting
  • Cardiovascular Risk
  • +2 more
  • Ziltivekimab
  • Placebo (ziltivekimab)
  • Birmingham, Alabama
  • +768 more
Dec 23, 2022